Home  >  News
Msc_Apr22 Advertisement
you can get e-magazine links on WhatsApp. Click here
  Daiichi Sankyo announces development progress of mRNA Covid19 vaccine in Japan,   May 27, 2022
  Valneva completes lot-to-lot phase 3 trial of single-shot chikungunya vaccine candidate,   May 26, 2022
  Amrita Vishwa Vidyapeetham receives CDSCO approval to initiate clinical trial of synthetic jaw-bone graft,   May 26, 2022
  Oxford Bio collaborates with Agenus to support clinical development of OBT's antibody drug conjugate OBT076 in combo with Agenus' CPI balstilimab,   May 26, 2022
  Bayer presents late-breaking data from exploratory post hoc analysis of prespecified pooled analysis FIDELITY at Heart Failure 2022 of ESC congress,   May 25, 2022
  Pfizer, BioNTech announce positive results from phase 2/3 trial of third 3-µg dose of Covid-19 vaccine in children 6 months to under 5 years of age,   May 25, 2022
  Two large Xarelto studies support effectiveness of dual pathway inhibition in patients with coronary artery disease and/or peripheral artery disease,   May 25, 2022
  Eli Lilly’s phase 3 LUCENT-2 study shows 50% of patients with ulcerative colitis treated with mirikizumab achieved clinical remission,   May 25, 2022
  Pfizer presents ELEVATE pivotal findings demonstrating etrasimod’s potentially best-in-class profile in ulcerative colitis,   May 25, 2022
  Visen Pharma announces positive results from phase 3 trial of once-weekly lonapegsomatropin in children with growth hormone deficiency,   May 24, 2022
  Hansa Biopharma completes enrollment in phase 2 study of imlifidase in AMR episodes post kidney transplantation,   May 24, 2022
  AstraZeneca to present new data from leading portfolio of cancer medicines at ASCO meeting,   May 24, 2022
  Antengene begins patient dosing in phase I/II SWATCH Study of Xpovio to treat B-cell non-Hodgkin lymphomas,   May 24, 2022
  AstraZeneca’s dapagliflozin meets primary endpoint in DELIVER phase III trial, reduces CVD fatality,   May 24, 2022
  Athersys partner, Healios announces positive results from TREASURE MultiStem ischemic stroke study,   May 23, 2022
  Regeneron Pharma announces phase 3 trial of Evkeeza in children aged 5 to 11 with homozygous familial hypercholesterolemia meets primary endpoint,   May 23, 2022
  Bayer to present key data across oncology portfolio showcasing significant advances in cancer care at 2022 ASCO meeting,   May 21, 2022
  Abbott presents data from structural heart transcatheter valve therapies at EuroPCR meeting,   May 21, 2022
  Voyager’s TRACER capsids demonstrate enhanced CNS transduction across species; new preclinical results bolster GBA1, Tau, SOD1 ALS gene therapy programmes,   May 20, 2022
  Innovators urged to plan pre-approval for accelerated pathways in clinical studies,   May 20, 2022

Copyright © 2016 Saffron Media Pvt. Ltd |